Evolving Paradigms in Prostate Cancer: The Integral Role of PSMA PET/CT in Primary Staging and Therapeutic Decision-Making
The incidence of prostate cancer is increasing, with most diagnosed with localized disease. Appropriate staging is crucial to ensure optimal treatments are delivered.
Category
  • Genitourinary
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
Cost $49.00
Patient Reported Outcomes Following MR-guided Radiotherapy for Prostate Cancer: A Systematic Review and Meta-analysis
In this activity participants will learn how MR-guided radiation therapy impacts patient-reported outcomes in patients with prostate cancer.
Category
  • Genitourinary
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $49.00
ROBIN Oligometastasis (OligoMET) Center: Using Biomarker Correlates from a Prostate Cancer Clinical Trial to Improve Future Outcomes
Metastasis is the final common lethal pathway for most cancer patient's demise and once cancer has metastasized, it was generally considered incurable.
Category
  • Genitourinary
  • Oligometastatic
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Renal SABR: Implementation of A New Standard of Care
This paper, using a question and answer format, comprehensively explores and presents the data for SABR treatment of patient’s with RCC. The data and clinical care aspects of patient selection, radiotherapy treatment planning and delivery and post-treatment follow-up care are presented.
Category
  • Genitourinary
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $49.00
ASTRO/KCA Joint Activity: Stereotactic Radiotherapy and Renal Cell Cancer, Overcoming Radioresistance and the Resistance to Radiate
This activity brings together an international panel and multidisciplinary expertise to discuss the emerging role of SABR to the primary in renal cell carcinoma (RCC).
Category
  • SBRT
  • Genitourinary
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Contemporary Multi-Disciplinary Management of Bladder Cancer
The management of bladder cancer is evolving across the spectrum of disease and stage and this educational activity is extremely valuable to the ASTRO membership.
Category
  • Genitourinary
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Radiation Therapy for Anal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline
This activity provides practitioners with the knowledge to recognize optimal RT management decisions for anal cancer.
Category
  • Guidelines
  • Genitourinary
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $49.00
Definitive and Salvage Radiation Therapy for Prostate Cancer
Improvements in technique, as well as advances in technology, have resulted in significant survival advances for those with localized and oligometastatic prostate cancer.
Category
  • Genitourinary
Format
  • Sessions onDemand
Credits
  • 3.00 AMA PRA Category 1 Credit™
  • 3.00 Certificate of Attendance
Cost $299.00
Contouring for Oligometastatic Prostate Cancer
Local therapies are increasingly being utilized in the treatment of oligometastatic prostate cancer. This webinar aims to review aspects of management and treatment of oligometastatic prostate cancer including discussions of contouring and plan evaluation.
Category
  • Genitourinary
Format
  • Sessions onDemand
  • Contouring
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
SBRT for Oligoprogressive Renal Cell Carcinoma and Prostate Cancer: A Case-based Panel Discussion
Use of SABR for selected patients with oligoprogressive (OP) prostate cancer and renal cell carcinoma (RCC) has been shown to have the potential to improve progression-free survival, extend the time to developing new metastatic lesions, and delay time to starting next systemic therapy without add
Category
  • Genitourinary
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00

Pages